NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,608 | -2.6% | 25,084 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $186,374 | +7.2% | 25,084 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $173,832 | -32.6% | 25,084 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $257,864 | -73.2% | 25,084 | -52.6% | 0.00% | -76.9% |
| Q3 2022 | $963,000 | +19.8% | 52,907 | +238.3% | 0.01% | +18.2% |
| Q2 2022 | $804,000 | +3.5% | 15,638 | +48.2% | 0.01% | +22.2% |
| Q1 2022 | $777,000 | -56.3% | 10,551 | -15.2% | 0.01% | -57.1% |
| Q4 2021 | $1,780,000 | +73.7% | 12,438 | +151.6% | 0.02% | +425.0% |
| Q3 2021 | $1,025,000 | +101.0% | 4,944 | -94.3% | 0.00% | -55.6% |
| Q2 2019 | $510,000 | – | 86,956 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |